Up-date on solitary plasmacytoma and its main differences with multiple myeloma

Experimental Oncology

Volumn 27, Issue 1, 2005, Pages 7-12

  Di Micco, P ^a   Di Micco, B ^b  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b UNIVERSITY OF SANNIO   (Italy)

Author keywords

Multiple myeloma; Solitary plasmacytoma

Indexed keywords

BETA 2 MICROGLOBULIN; CALCIUM;

AMYLOIDOSIS; AUTOIMMUNE DISEASE; BONE DISEASE; BONE INJURY; CALCIUM BLOOD LEVEL; CANCER LOCALIZATION; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; HEMATOLOGIC DISEASE; HUMAN; IMMUNOPATHOLOGY; INFECTION; KIDNEY DYSFUNCTION; KIDNEY FAILURE; LABORATORY TEST; MULTIPLE MYELOMA; NEUROLOGIC DISEASE; PARAPROTEINEMIA; PLASMA CELL; PLASMACYTOMA; PROGNOSIS; REVIEW;

AGED; ANIMALS; BONE NEOPLASMS; HUMANS; MIDDLE AGED; MULTIPLE MYELOMA; PLASMACYTOMA;

EID: 17444391666     PISSN: 02043564     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. William JW, Beutker E, Erslev AJ, Licthmann MA. Hematology. New York: McGraw Hill, Inc, 1990; 1140-7.
2. Diebold J. World Health Organization classification of malignant lymphomas. Exp Oncol 2001; 23: 101-3.
3. Pisano JJ, Coupland R, Chen SY, Miller AS. Plasmacytoma of the oral cavity and jaws: a clinicopathological study of 13 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997; 83: 265-71.
4. Knowling MA, Harwood AR, Bergsagel DE. Comparison of extramedullary plasmacytoma with solitary and multiple plasma cell tumor of bone. J Clin Oncol 1983; 1: 255-62.
5. Di Micco P, Niglio A, Torella R, Di Micco B. Solitary plasmacytoma of the jaw occurring in a elderly woman affected by hepatitis C virus infection: a case report. Tumori 2002; 88: 421-4.
6. Ferrer AC, Ferrer AE, Fernandez IA, Pinzo BJ, Ramos FV, Rancho TR. Solitary plasmacytoma of the mandibole. Report of one case and review of the literature. A Otorrinolaringol Ibero Am 1995; 22: 609-18.
7. Huang JS, Ho YP, Ho KY, Wu YM, Chen CC, Wang CC, Tsai CC, Lin SF. Multiple myeloma with oral manifestation report of two cases. Kaoshiung J Med Sci 1997; 13: 388-94.
8. Cotticelli G, Di Micco P, Mastroianni M, Ciavattone A, Bartiromo D, Torella R. Long term survival of a young man with λ-IgD plasmacytoma. Exp Oncol 2003; 25: 313-4.
9. th Ed. New York: McGraw Hill Inc, 2001; 727-33.
10. Kadokura M, Tanio N, Nonaka M, Yamamoto S, Kataoka D, Kushima M, Kimura S, Nakamaki T, Sato I, Takaba T. A surgical case of solitary plasmacytoma of rib origin with biclonal gammopathy. Jpn J Clin Oncol 2000; 30: 191-5.
11. Persico M, De Marino FA, Di Giacomo Russo G, Persico E, Morante A, Palmentieri B, Torella R. Prevalence and incidence of cryoglobulins in hepatitis C virus-related chronic hepatitis patients: a prospective study. Am J Gastroenterol 2003; 98: 884-8.
12. De Vita S, Sansonno D, Dolcetti R, Ferraccioli G, Carbone A, Cornacchiulo V, Santini G, Crovatto M, Giorgini A, Dammacco F, Bolocchi M. Hepatitis C virus within a malignant lymphoma lesion in the corse of type II mixed cryoglobulinaemia. Blood 1995; 86: 1887-992.
13. Ing EB, Woolf IZ, Younge BR, Bjornsson J, Leavitt JA. Systemic amyloidosis with temporal artery involvement mimicking temporal arteritis. Ophtalmic Surg Lasers 1997; 28: 328-31.
14. River GL, Tewksbury DA, Fudenberg HH. "Non-secretory" multiple myeloma. Blood 1972; 40: 204-6.
15. Hurez D, Preud' Homme JL, Seligmann M. Intracellular " monoclonal" immunoglobulin in non-secretory human myeloma. J Immunol 1970; 104: 263-4.
16. Fonseca R, Blood E, Rue M, Harrington D, Oken MM, Kyle RA, Dewald GW, Van Ness B, Van Wier SA, Henderson KJ, Bailey RJ, Greipp PR. Clinical and biologic implications of recurrent genomic aberrations in myeloma. Blood 2003; 101: 4569-75.
17. Luppi M, Ferrari MG, Bonaccorsi G, Longo G, Numi F, Birozzi P, Marasca R, Mussini C, Torelli G. Hepatitits C virus infection in subsets of neoplastic lymphoproliferation not associated with cryoglobulinaemia. Leukemia 1996; 10: 351-5.
18. Persico M, De Renzo A, Persico E, Torella D, Rotoli B, Torella R. Chronic liver disease and lymphoproliferative disorders in HCV-positive patients: a working hypothesis. J Hepatol 1998; 29: 857-9.
19. Mazzaro C, Zagonel V, Monfardini S, Tulissi P, Passini E, Fanni M, Sorio R, Bortolus R, Crovatto M, Santini G, Tiribelli C, Sasso F, Masutti R, Pozzato G. Hepatitis C virus and non-Hodgkin's lymphomas. Br J Haematol 1996; 94: 544-50.
20. Hausfater P, Rosenthal E, Cacoub P. Lymphoproliferative disease and hepatitis C virus infection. Ann Med Interne 2000; 151: 53-7.
21. Zuckerman E, Zuckerman T, Levine Am, Douer D, Gutenkust K, Mizokami M, Qian DG, Velankar M, Nathwani BN, Fong TL. Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma. Ann Intern Med 1997; 127: 423-8.
22. Radkowsky M, Kubicka J, Kisiel E, Cianciara J, Novicki M, Rasela J, Laskus T. Detection of active hepatitis C virus and hepatitis G virus/GB virus C replication in bone marrow in human subjects. Blood 2000; 95: 3986-9.
23. Montella M, Crispo A, Russo F, Ronga D, Tridente V, Tamburini M. Hepatitis C virus infection and new association with extrahepatic disease: multiple myeloma. Haematologica 2000; 85: 833-4.
24. Wack A, Soldaini E, Tseng C, Nuti S, Klimpel G, Abrignani S. Binding of the hepatitis C virus envelope protein E2 to CD 81 provides a co-stimulatory signal for human T-cells. Eur J Immunol 2001; 31: 166-75.
25. Mayo MJ. Extrahepatic manifestations of hepatitis C infection. Am J Med Sci 2003; 325: 135-48.
26. Singh D, Wadhwa J, Kumar L, Raina V, Agarwal A, Kochupillai V. POEMS syndrome: experience with fourteen cases. Leuk Lymphoma 2003; 44: 1749-52.
27. Scutellari PN, Orzincolo C. Bone disease in multiple myeloma. Analysis of 253 controlled cases, with reappraisal of diagnostic criteria and current imaging tecqniques. Radiol Med 1993; 85: 235-46.
28. Ruiz Montes F, Rene Espinet JM, Buenestado Garcia J, Panades Siurana MJ, Egido Garcia R, Ramos Yanes J. Primary gastric plasmacytoma of rapid growth presenting with upper gatrointestinal bleeding. Am J Gastroenterol 1995; 90: 1349-50.
29. Galieni P, Cavo M, Pulsioni A, Avvisati G, Bigazzi C, Neri S, Caliceti U, Benni M, Ronconi S, Lauria F. Clinical outcome of extramedullary plasmacytoma. Haematologica 2000; 85: 47-51.
30. Brame LA, Dwivedi R, Rice TW, Skierczynski PA. Atrial plasmacytoma and hypercalcemia. Endocr Pract 2003; 9: 225-8.
31. Mandagere ICA, Schimke RN, Kyner JL, Bateia PS. An unusual cellar mass: solitary plasmacytoma. Endocr Pract 1998; 4: 382-6.
32. Urbanska-Rys H, Wierzbowska A, Robak T. Circulating angiogenic cytokines in multiple myeloma and related disorders. Eur Cytokine Network 2003; 14: 40-51.
33. Lauta VM. A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutical implications. Cancer 2003; 97: 2440-52.
34. Urbanska-Rys H, Robak T. High serum level of endostatin in multiple myeloma at diagnosis but not in the plateau phase after treatment. Mediators Inflamm 2003; 12: 229-35.
35. Standal T, Borset M, Sundan A. The role of osteopontin in adhesion, migration, cell survival and bone remodelling. Exp Oncol 2004; 26: 179-84.
36. Standal T, Hjorth-Hansen H, Rasmussen T, Dahl IMS, Lenhoff S, Brenne AT, Seidel C, Baykov V, Waage A, Borset M, Sundan A, Hjertner O. Osteopontin is an adesive factor for myeloma cells and is found in increased levels in plasma from patients with multiple myeloma. Haematologica 2004; 89: 174-82.
37. Hotte SJ, Winqvist EW, Stitt L, Wilson SM, Chambers AF. Plasma osteopontin: associations with survival and metastasis to bone in men with hormone-refractory prostate carcinoma. Cancer 2002; 95: 506-12.
38. Di Micco B, Metafora S, Colonna G, Carteni M, Ragone R, Macalello MA, Di Micco P, Baroni A, Catalanotti P, Tufano MA. Porins from Salmonella typhimurium accelerate human blood coagulation in vitro by selective stimulation of thrombin activity: implication in septic shock DIC pathogenesis. J Endotoxin Res 2001; 7: 211-7.
39. Levi M. Pathogenesis and treatment of disseminated intravascular coagulation in the septic patient. J Crit Care 2001; 16: 167-77.
40. Fornasieri A, Bernasconi P, Ribero ML, Sinico RA, Fasola M, Zhou J, Portera G, Tagger A, Gibelli S, D'Amico G. Hepatitis C virus (HCV) in lymphocytes subsets and in B lymphocytes expressing rheumatoid factor cross-reacting idiotype in type II mixed cryoglobulinaemia. Clin Exp Immunol 2000; 122: 400-3.
41. Falanga A. Mechanism of hypercoagulation in malignancy and during chemotherapy. Haemostasis 1998; 28: 50-60.
42. Di Micco P, D'Uva M. Editorial comment. To understand the two way clinical association between cancer and thrombophilia. Exp Oncol 2003; 25: 243-4.
43. Sipe JD. Amyloidosis. Crit Rec Clin Lab Sci 1994; 31: 325-54.
44. Jones LA. Advances in amyloidosis. Curr Opin Rheumatol 1993; 5: 62-76.
45. th Ed. New York: McGraw Hill Inc, 2001; 1974-9.
46. Benson MD. Inherited amyloidosis. J Med Genet 1991; 28: 73-8.
47. Tabachnik TT, Levine B. Multiple myeloma involving the jaw and oral soft tissues. J Oral Surg 1976; 34: 931-3.
48. Hutson TE, Hoffman GS. Temporal concurrence of vasculitis and cancer: a report of 12 cases. Arthritis Care Res 2000; 13: 417-23.
49. Rodon P, Friocourt P, Blanchet S, Levallois D. Temporal artery involvement revealing AL amyloidosis and Ig D monoclonal gammopathy. J Rheumatol 1996; 23: 189-90.
50. Myers B, Lachmann H, Russel NH. Novel combination chemotherapy for primary (AL) amyloidosis myeloma: clinical, laboratory and serum amyloid-P protein scan improvement. Br J Haematol 2003; 121: 816-7.
51. Singh D, Wadhwa J, Kumar L, Raina V, Agarwal A, Kochupillai V. POEMS syndrome: experience with fourteen cases. Leuk Lymphoma 2003; 44: 1749-52.
52. Cavo M, Benni M, Ronconi S, Fiacchini M, Gozzetti A, Zamagni E, Cellini C, Tosi P, Baccarani M, Tura S. Melphalan-prednisone (MP) versus alternating combination VAD/MP or VDN/MP as primary therapy for multiple myeloma: final analysis of a randomized clinical study. Haematologica 2002; 87: 934-42.
53. Bolek M, Sztuk S. Ten years survival of solitary plasmacytoma. Pol Merkuriusz Lek 2001; 11: 160-1.
54. Piccinini L, Artusi T, Bonacorsi G, Arigliano V. Acute leukemia of plasmablastic type as terminal phase of multiple myeloma. Haematologica 2002; 87: EIM04.
55. Crawford J, Dale DC, Lyman GH. Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management. Cancer 2004; 100: 228-37.